---
figid: PMC1083933__kvf01402
figlink: /pmc/articles/PMC1083933/figure/kvf014f2/
number: F2
caption: Fig. 2. Model for the signalling pathways that act at different stages of
  Xenopus meiotic maturation in response to progesterone. RINGO–CDK1 complexes stimulate
  the transition between G2 and meiosis (M) I, whereas cyclin–CDK1 complexes are required
  for the transition between MI and MII under the influence of Cdc25 and Myt1. The
  MAP kinase pathway arrests cells in MII in response to activation by mos, possibly
  through stimulating Bub1. Fertilization is required to release the cells from this
  arrest.
pmcid: PMC1083933
papertitle: Cell cycle trials in Salamanca.
reftext: Jonathon Pines. EMBO Rep. 2002 Jan 15;3(1):17-21.
pmc_ranked_result_index: '3497'
pathway_score: 0.9454521
filename: kvf01402.jpg
figtitle: Cell cycle trials in Salamanca
year: '2002'
organisms: Homo sapiens
ndex: 547ebe2c-dec4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC1083933__kvf01402.html
  '@type': Dataset
  description: Fig. 2. Model for the signalling pathways that act at different stages
    of Xenopus meiotic maturation in response to progesterone. RINGO–CDK1 complexes
    stimulate the transition between G2 and meiosis (M) I, whereas cyclin–CDK1 complexes
    are required for the transition between MI and MII under the influence of Cdc25
    and Myt1. The MAP kinase pathway arrests cells in MII in response to activation
    by mos, possibly through stimulating Bub1. Fertilization is required to release
    the cells from this arrest.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - CDK1
  - CDC25C
  - BUB1
  - CDC25B
  - CDC25A
  - RPS6KA1
  - RPS6KA2
  - RPS6KA6
  - RPS6KA5
  - BHLHE23
  - RPS6KA4
  - MYT1
  - MOS
  - RPS6KB1
  - RPS6KB2
  - MAP2K2
  - RPS6KA3
  - Progesterone
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: +CDK1
  symbol: CDK1
  source: hgnc_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: Cdc25
  symbol: CDC25
  source: bioentities_symbol
  hgnc_symbol: CDC25C
  entrez: '995'
- word: Bub1
  symbol: BUB1
  source: hgnc_symbol
  hgnc_symbol: BUB1
  entrez: '699'
- word: Cdc25
  symbol: CDC25
  source: bioentities_symbol
  hgnc_symbol: CDC25B
  entrez: '994'
- word: Cdc25
  symbol: CDC25
  source: bioentities_symbol
  hgnc_symbol: CDC25A
  entrez: '993'
- word: Rsk
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: Rsk
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: Rsk
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: Rsk
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: B4
  symbol: Beta4
  source: hgnc_alias_symbol
  hgnc_symbol: BHLHE23
  entrez: '128408'
- word: Rsk
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: Myt1
  symbol: MYT1
  source: hgnc_symbol
  hgnc_symbol: MYT1
  entrez: '4661'
- word: mos
  symbol: MOS
  source: hgnc_symbol
  hgnc_symbol: MOS
  entrez: '4342'
- word: Rsk
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: Rsk
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Rsk
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
chemicals:
- word: Progesterone
  source: MESH
  identifier: D011374
diseases: []
figid_alias: PMC1083933__F2
redirect_from: /figures/PMC1083933__F2
figtype: Figure
---
